INCRELEX (mecasermin injection) is used for the treatment of patients with recombinant human insulin-like growth factor-1 (rhIGF-1)

INCRELEX® (mecasermin [rDNA origin] injection) is indicated for the treatment of growth failure in children with severe primary IGF-1 deficiency or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to GH.

Increlex®'s active principle (IGF-1) for the treatment of Severe Primary IGF-1 Deficiency (Primary IGFD) is manufactured by Lonza Biologics Inc. at its Hopkinton, MA facility. Ipsen and Lonza will continue to work with FDA in the supply of US patients with this important drug.

INCRELEX (mecasermin injection) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of INCRELEX (mecasermin injection) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the INCRELEX (mecasermin injection) medicine cost price in India.

The order for INCRELEX (mecasermin injection) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Mecasermin (INN) (brand name Increlex), also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone deficiency or Laron syndrome (growth hormone insensitivity).

INCRELEX® (mecasermin [rDNA origin] injection) Initial U.S. Approval: 2005

Generic Name: mecasermin

INCRELEX® is a sterile solution supplied in a multiple dose glass vial at a concentration of 10 mg per mL (40 mg per vial).

Increlex (mecasermin injection)

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to Increlex (mecasermin injection) on the Named Patient Import basis in India.

INCRELEX (mecasermin)

News / Update for INCRELEX (mecasermin injection).

For INCRELEX (mecasermin injection) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Ipsen takes step forward in the resupply of Increlex for the USA For More Details

Ipsen delivers strong results for the first half of 2019 with robust double-digit sales growth and improved Core Operating margin and upgrades its guidance for full year 2019 For More Details

INCRELEX (mecasermin) manufacturer and suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand INCRELEX (mecasermin) on prescription and Import License in Patient's Name only.

For overseas patients, INCRELEX (mecasermin) can be made available in Send your enquiry to find INCRELEX (mecasermin) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

Steps to access INCRELEX (mecasermin) on the Named Patient Import basis.

Step 1.
You send a request for your medicine online:-
Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2.
We verify your prescription and medical details:-
Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3.
We source your medicine:-
Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4.
We deliver your medicine:-
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Documentation for Named-Patient import to access INCRELEX (mecasermin).

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified professionals of pharmaceutical Industry. Registration Number :07AAFFI2544E1ZO under GST Act. Specialized in Oncology Pharmacy. Helped more than 6,000 patients.

Helps you access to a FDA approved medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery.

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur